Technical Analysis for AGL - Angle Plc

Grade Last Price % Change Price Change
F 12.50 2.04% 0.25
AGL closed up 2.04 percent on Thursday, March 28, 2024, on 89 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Apr 15
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 2.04%
Wide Bands Range Expansion 2.04%
Down 3 Days in a Row Weakness 2.04%
Lower Bollinger Band Touch Weakness 2.04%
Oversold Stochastic Weakness 2.04%

   Recent Intraday Alerts

Alert Time
Up 5% 1 day ago
Rose Above Previous Day's High 1 day ago
Up 3% 1 day ago
Down 2% 1 day ago
Down 1% 1 day ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Angle Plc Description

ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Cancer Medical Specialties Monitoring Nature Clinical Medicine Oncology Fluid Offers Products Blood Drug Development Tumor Personalized Cancer Anatomical Pathology Biopsy Circulating Tumor Cell Medical Diagnostic

Is AGL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.4
52 Week Low 9.0667
Average Volume 1,328,805
200-Day Moving Average 14.09
50-Day Moving Average 15.98
20-Day Moving Average 14.30
10-Day Moving Average 13.33
Average True Range 1.04
RSI (14) 32.89
ADX 17.2
+DI 18.43
-DI 22.46
Chandelier Exit (Long, 3 ATRs) 13.86
Chandelier Exit (Short, 3 ATRs) 15.13
Upper Bollinger Bands 16.60
Lower Bollinger Band 12.00
Percent B (%b) 0.11
BandWidth 32.17
MACD Line -1.03
MACD Signal Line -0.87
MACD Histogram -0.1559
Fundamentals Value
Market Cap 32.57 Million
Num Shares 261 Million
EPS -0.09
Price-to-Earnings (P/E) Ratio -138.89
Price-to-Sales 23.44
Price-to-Book 1.33
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.75
Resistance 3 (R3) 14.83 14.17 14.38
Resistance 2 (R2) 14.17 13.59 14.13 14.25
Resistance 1 (R1) 13.33 13.24 13.75 13.25 14.12
Pivot Point 12.67 12.67 12.88 12.63 12.67
Support 1 (S1) 11.83 12.09 12.25 11.75 10.88
Support 2 (S2) 11.17 11.74 11.13 10.75
Support 3 (S3) 10.33 11.17 10.63
Support 4 (S4) 10.25